Infection-related rheumatic syndromes
Alfred Kim, MD, PhD
Washington University School of Medicine
St. Louis, MO, United States
Disclosure(s): Alexion Pharmaceuticals: Consultant (Ongoing); AstraZeneca: Consultant (Ongoing); Aurinia Pharmaceuticals: Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Exagen Diagnostics: Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Foghorn Therapeutics: Grant/Research Support (Ongoing); GlaxoSmithKline: Consultant (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Kypha Inc.: Consultant (Ongoing), Intellectual Property/Patents (Ongoing); Pfizer: Consultant (Ongoing)
Jeffrey Sparks, MD, MSc
Brigham and Women's Hospital
Boston, MA, United States
Disclosure(s): No financial relationships with ineligible companies to disclose
Puja Mehta, MD
University College London (UCL)
london, United Kingdom
Disclosure information not submitted.
Cassandra Calabrese, DO
Cleveland Clinic Foundation
Cleveland Heights, OH, United States
Disclosure information not submitted.
COVID-19 Potpourri: Q&A with experts